Zobrazeno 1 - 10
of 116
pro vyhledávání: '"H L Atkins"'
Autor:
Brian T. Helenbrook, H. L. Atkins
Publikováno v:
AIAA Journal. 44:566-575
Publikováno v:
British Journal of Haematology. 93:280-286
The rhombotin 2 gene was identified by its association with a recurrent chromosome translocation (11;14)(p13;q11), occurring in T-cell acute lymphoblastic leukaemias (ALLs). High levels of RBTN2 have been found in T-cell leukaemias carrying the trans
Publikováno v:
Leukemia
Identification of genes that regulate clonogenicity of acute myelogenous leukemia (AML) cells is hindered by the difficulty of isolating pure populations of cells with defined proliferative abilities. By analyzing the growth of clonal siblings in low
Publikováno v:
Blood. 77:2577-2582
Erythropoietin (Epo) regulates the growth and differentiation of erythroid cells by binding to a specific receptor. We characterized the native Epo receptor on erythroleukemia cell lines by ligand blotting. Solubilized cell membrane proteins were sep
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(3)
Current dosimetric models of the brain and head lack the anatomic detail needed to provide the physical data necessary for suborgan brain dosimetry. During the last decade, several new radiopharmaceuticals have been introduced for brain imaging. The
Autor:
H L, Atkins, S C, Srivastava
Publikováno v:
Journal of nuclear medicine technology. 26(2)
This continuing education article reviews radionuclide bone therapy agents that are available commercially and introduces agents that are being evaluated for future use. Currently these agents are used to provide pain palliation from metastases to bo
Autor:
S C, Srivastava, H L, Atkins, G T, Krishnamurthy, I, Zanzi, E B, Silberstein, G, Meinken, L F, Mausner, F, Swailem, T, D'Alessandro, C J, Cabahug, Y, Lau, T, Park, S, Madajewicz
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(1)
The physical characteristics of Sn-117m combined with the biodistribution of the compound tin-117m (Stannic, 4+) diethylenetriaminepentaacetic acid (Sn-117m DTPA) suggest that it should be an excellent agent for the palliation of pain from bony metas
Autor:
H, Susskind, D A, Weber, Y H, Lau, T L, Park, H L, Atkins, D, Franceschi, A G, Meek, M, Ivanovic, L, Wielopolski
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(6)
This study evaluates the use of the 99mTc-DTPA aerosol lung clearance method to investigate radiation-induced lung changes in eight patients undergoing radiotherapy for lung or breast carcinoma. The sensitivity of the method was compared with chest r
Tin-117m(4+)DTPA: pharmacokinetics and imaging characteristics in patients with metastatic bone pain
Autor:
G T, Krishnamurthy, F M, Swailem, S C, Srivastava, H L, Atkins, L J, Simpson, T K, Walsh, F R, Ahmann, G E, Meinken, J H, Shah
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(2)
Biokinetics and imaging characteristics of 117mSn(4+)DTPA have been studied in patients with metastatic bone pain.Seventeen patients with bone pain due to metastasis were given three dose levels: 180 microCi/kg (6.66 MBq/kg), 229 microCi/kg (8.47 MBq
Autor:
H L, Atkins, S C, Srivastava
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 40(3)
Bone seeking radiopharmaceuticals consist of diagnostic (primarily single photon emitters) and therapeutic agents. The therapeutic radiopharmaceuticals are utilized on the basis of their particulate emissions (primarily beta-) and thus are treated di